| scholarly article | Q13442814 |
| P2093 | author name string | Richard A D Carano | |
| Jill Fredrickson | |||
| Shelby K Wyatt | |||
| Andrea Pirzkall | |||
| Lee S Rosen | |||
| Natalie J Serkova | |||
| Ina Rhee | |||
| Alex de Crespigny | |||
| Alberto Bessudo | |||
| Colin Weekes | |||
| P2860 | cites work | High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol. | Q46842885 |
| Vessel size imaging in humans. | Q47391159 | ||
| Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification | Q47392014 | ||
| Vessel size imaging using dual contrast agent injections | Q47589338 | ||
| In vivo assessment of tumoral angiogenesis. | Q47990042 | ||
| NMR imaging of changes in vascular morphology due to tumor angiogenesis | Q48335611 | ||
| Microvessel density estimation in the human brain by means of dynamic contrast-enhanced echo-planar imaging | Q48401141 | ||
| Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies. | Q48638550 | ||
| Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. | Q52299118 | ||
| Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. | Q55473086 | ||
| MR imaging of microvasculature. | Q55475365 | ||
| Quantification of viable tumor microvascular characteristics by multispectral analysis. | Q64936571 | ||
| Tumor blood volume determination by using susceptibility-corrected DeltaR2* multiecho MR | Q84300035 | ||
| Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response | Q28384680 | ||
| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. | Q30490422 | ||
| Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival | Q30579847 | ||
| Vessel size imaging | Q30637730 | ||
| Vessel caliber--a potential MRI biomarker of tumour response in clinical trials. | Q30651792 | ||
| Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange | Q32064610 | ||
| The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI. | Q33306932 | ||
| Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review | Q33503551 | ||
| Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
| In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model | Q34132818 | ||
| Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic | Q34569109 | ||
| Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol | Q34722530 | ||
| Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study | Q35035576 | ||
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles | Q35196287 | ||
| MRI using ferumoxytol improves the visualization of central nervous system vascular malformations | Q36142273 | ||
| High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle | Q36842826 | ||
| Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? | Q37098753 | ||
| Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives | Q37257444 | ||
| Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain | Q37275044 | ||
| Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model | Q37354846 | ||
| Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies | Q37983692 | ||
| Imaging the microvessel caliber and density: Principles and applications of microvascular MRI. | Q38244289 | ||
| Quantification of tumor tissue populations by multispectral analysis | Q40581417 | ||
| Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney | Q41953470 | ||
| Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging. | Q44114516 | ||
| Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis | Q46207764 | ||
| P433 | issue | 2 | |
| P921 | main subject | phase I clinical trial | Q5452194 |
| P304 | page(s) | 814-825 | |
| P577 | publication date | 2016-02-26 | |
| P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
| P1476 | title | Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population | |
| P478 | volume | 77 |
| Q36301599 | A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging |
| Q32176092 | Monitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI. |
| Q47367815 | Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI. |
| Q33710955 | Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation |
| Q64986131 | Perspectives: MRI of angiogenesis. |
| Q89736571 | Prediction of Anti-cancer Nanotherapy Efficacy by Imaging |
Search more.